CCM Duopharma Sales Continue To Grow

Despite a challenging operating environment, the leading generic drug manufacturer in Malaysia, CCM Duopharma, has released decent financial results. This development underlines BMI's view that pharmaceutical and healthcare firms operating in the South East Asian country are resilient to the global economic

To read the full article, please sign in or take a free trial.